Compass Oncology - East — Tualatin, Oregon

Compass Oncology - East is a clinical research site located in Tualatin, Oregon, United States 97062.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Compass Oncology - East has participated in 1 clinical trials.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC).

Sponsors: Constellation Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology - East?

Compass Oncology - East has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology - East conducted?

Compass Oncology - East has 1 clinical trials on record. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC).

Is Compass Oncology - East accredited by Crixeo Health?

Compass Oncology - East has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Oncology - East?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.